Invex Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 3, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	9	7	5	15	37	47
Market Cap Growth	64.47%	48.33%	-70.00%	-59.60%	-21.43%	-46.04%
Enterprise Value	5	1	-2	-10	6	14
Last Close Price	0.13	0.09	0.06	0.05	0.13	0.16
PS Ratio	41.01	29.20	3.72	32.74	204.12	-
PB Ratio	2.07	1.27	0.79	0.71	1.31	1.48
P/TBV Ratio	2.07	1.27	0.79	0.71	1.31	1.48
EV/Sales Ratio	20.95	3.85	-	-	32.02	-
Net Debt / Equity Ratio	-1.01	-1.02	-1.06	-1.06	-1.03	-1.02
Asset Turnover	0.04	0.04	0.08	0.02	0.01	-
Quick Ratio	26.76	24.79	14.18	14.50	29.36	49.71
Current Ratio	26.76	24.79	14.18	14.50	29.36	49.71
Return on Equity (ROE)	-16.83%	-8.72%	-12.20%	-31.18%	-13.05%	-8.09%
Return on Assets (ROA)	-12.75%	-7.65%	-9.22%	-20.43%	-8.10%	-5.16%
Return on Capital Employed (ROCE)	-23.80%	-13.50%	-37.50%	-40.30%	-14.20%	-7.60%
Earnings Yield	-8.90%	-7.13%	-36.41%	-51.56%	-10.63%	-4.82%
Buyback Yield / Dilution	0.29%	-0.51%	-0.19%	-0.02%	-0.03%	-33.77%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.